Published in Medical Letter on the CDC and FDA, May 4th, 2008
As previously announced, Biopure has been invited by the MHRA to meet with the MHRA team of reviewers to discuss issues...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.